Research graph
References from Prognostic impact of need for re-induction based on day-14 residual disease and age-adapted consolidation strategy in acute myeloid leukemia. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1182/blood.2022016867
10.1182/blood.2022016867 · 2022 · External reference
Unresolved reference
External reference
10.1016/j.leukres.2025.108121
10.1016/j.leukres.2025.108121 · 2025 · External reference
10.1002/ajh.24818
10.1002/ajh.24818 · 2017 · External reference
10.3324/haematol.2021.279134
10.3324/haematol.2021.279134 · 2022 · External reference
10.1002/ajh.27429
10.1002/ajh.27429 · 2024 · External reference
10.1002/ajh.27625
10.1002/ajh.27625 · 2025 · External reference
10.3324/haematol.2013.091819
10.3324/haematol.2013.091819 · 2014 · External reference
10.1016/j.clml.2018.11.001
10.1016/j.clml.2018.11.001 · External reference
10.1016/j.clml.2019.03.024
10.1016/j.clml.2019.03.024 · 2019 · External reference
10.1182/blood.2021013626
10.1182/blood.2021013626 · 2021 · External reference
10.1016/j.beha.2014.10.004
10.1016/j.beha.2014.10.004 · 2014 · External reference
10.3390/cancers17050900
10.3390/cancers17050900 · 2025 · External reference
10.1016/j.blre.2021.100873
10.1016/j.blre.2021.100873 · 2022 · External reference
10.1200/jco.2016.70.6374
10.1200/jco.2016.70.6374 · 2017 · External reference
